Horizon Kinetics Medical ... (MEDX)
NASDAQ: MEDX
· Real-Time Price · USD
30.84
1.25 (4.22%)
At close: Oct 01, 2025, 12:45 PM
4.22% (1D)
| Bid | 29.99 |
| Market Cap | 18.01M |
| AUM | 17.46M |
| NAV | 29.35 |
| EPS (ttm) | 1.28 |
| PE Ratio (ttm) | 24.09 |
| Shares Out | 583.96K |
| Inception Date | Jan 27, 2023 |
| Ask | 38.4 |
| Volume | 2,440 |
| Open | 29.90 |
| Previous Close | 29.59 |
| Day's Range | 29.90 - 30.84 |
| 52-Week Range | 23.46 - 31.05 |
| Holdings | 50 |
| Expense Ratio | 0.85% |
About MEDX
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics, employing a long-term perspective to capture returns from intrinsic valuation realization and scientific discovery.
Asset Class Equity
Ticker Symbol MEDX
Inception Date Jan 27, 2023
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 63.33% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 13.97% |
| Abbvie Inc. | ABBV | 9.81% |
| Novartis Ag | NVS | 6.82% |
| Alnylam Pharmaceutic... | ALNY | 6.36% |
| Johnson & Johnson | JNJ | 5.00% |
| Astrazeneca PLC | AZN | 4.87% |
| Ionis Pharmaceutical... | IONS | 4.58% |
| Bristol-myers Squibb... | BMY | 4.24% |
| Crispr Therapeutics ... | CRSP | 3.85% |
| Alkermes Plc | ALKS | 3.83% |
Dividends Dividend Yield 1.88%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 24, 2024 | $0.5023 | Dec 26, 2024 |
| Dec 27, 2023 | $1.6423 | Dec 29, 2023 |
4 months ago · accessnewswire.com
Horizon Kinetics Holding Corporation Reports First Quarter ResultsHighlights for the Quarter ended March 31, 2025: Management and advisory fee revenue of $18.9 million for the quarter ended March 31, 2025, an increase of 58% over the first quarter of 2024 Net income...